Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal.
Audacious: We Are Bold and Innovative.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

The Director of National Accounts will report to the Executive Director, Access & Reimbursment and will be responsible for leadership and management of payer and other assigned accounts.  This leader will manage all aspects of payer, pathway, and other engagements and will devise and execute customer specific strategies to support the appropriate coverage of Replimune commercial products.  This position will integrate cross functionally with internal and external partners to ensure patient and provider access to support commercial launch and growth plans. 

This position can be based either in our Woburn office or be a remote role

• Our Woburn location welcomes hybrid work!  Local candidates are expected to be on-site 2 days per week.
• Remote candidates (i.e., living beyond 65 miles of our Woburn HQ) must be open to 10-25% travel to our Woburn HQ, every 6-8 weeks or as business needs require. Addiitonally this position requires significant travel for live in-person customer engagements 

• Responsible for account specific engagement approaches, strategic and tactical development, and account deployment to maximize access and reimbursement for product portfolio. If necessary, contract performance may be required.
• Develop, maintain, and execute pre-launch, launch, and post-launch business and account plans; update as changes require.
• Meet access goals and ensure medical coverage policies and pathways are consistent with the FDA approved prescribing information.
• Collaborate with field teams (Sales, Medical, Nurse Educators, etc.) to identify any access barriers and partner with colleagues to mitigate.
• Collaborate with field teams to create and facilitate the most optimal customer experience and, when necessary, address service gaps in a timely manner.
• Proactively communicate payer criteria and terms to relevant field teams.
• Gather information and create analyses to inform organizational understanding of the current and evolving influence of payer market dynamics, risks, and competitive behaviors with potential business impact.
• Collaborate with Sales, Marketing, Operations, Medical Affairs, Regulatory, Legal, and Compliance to ensure alignment with all deliverables related to access and reimbursement.
• Engage with leadership of non-payer specific accounts such as community oncology GPOs, National and State Oncology Associations as well as VA/DoD level accounts as necessary.
• Ensure compliance with corporate policies and procedures, as well as US Healthcare laws and regulations.
• Travel as required for live in-person customer engagements.

Other responsibilities

• Willing to undertake additional responsibilities outside of your area of expertise as opportunity presents

Educational requirements:

Bachelors degree required,  MBA strongly preferred

Experience and skill requirement:

• Bachelor’s degree required; MBA strongly preferred
• 10+ years of biotech/pharma experience with at least 8 years of direct experience in payer account management
• Understanding of oncology buy and bill model with commercial and government-based payers; recent experience preferred
• Comprehensive understanding of the current and evolving payer oncology management landscape, both from a medical and pharmacy benefit perspective
• Experience with pathways submission protocols and product review/positioning requirements
• Exceptional customer business planning, tactical planning, and successful execution skills
• Strong leadership, communication, and collaboration skills and the ability to drive consensus
• Exemplary presentation skills with demonstrated success presenting both to internal and within external key stakeholder engagements
• Demonstrated negotiation and contracting skills and ability to develop sound business rationale to influence external decision makers
• Ability to thrive in a fast-paced start-up environment with high expectations and accountability for the quality and timing of critical deliverables
• Experience influence management across external and internal stakeholders
• Self-motivated & collaborative team player
• Willing to undertake additional responsibilities outside area of expertise
• Proficient in Microsoft Word, PowerPoint, and Excel

This position can be based either in our Woburn office or be a remote role

• Our Woburn location welcomes hybrid work!  Local candidates are expected to be on-site 2 days per week.
• Remote candidates (i.e., living beyond 65 miles of our Woburn HQ) must be open to 10-25% travel to our Woburn HQ, every 6-8 weeks or as business needs require. Addiitonally this position requires significant travel for live in-person customer engagements 

About Replimune 
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

We are an Equal Opportunity Employer.